Lucy Ellis, PhD, is a DMPK leader with over 12 years of experience in drug discovery and development. Presently, Lucy serves as the Director of DMPK at Recursion, having previously held roles at Exscientia and Pharmaron where they specialized in designing and executing DMPK/ADME strategies. Lucy's extensive background includes significant contributions at AstraZeneca and the University of Dundee in various aspects of drug metabolism and pharmacokinetics. An accomplished academic, Lucy earned a PhD in Medicine and Therapeutics from the University of Aberdeen and has conducted impactful research throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices